Presentations
Presentations from Neola Medical
Neola Medical participates in several capital market days and other investor meetings. Below we collect recordings from stock market days and other occasions. The presentations are held in Swedish or English.
Redeye Interview with CEO Hanna Sjöström
Following the release of Neola Medical’s Q4 2024 report, Redeye Equity Research Analyst Gustaf Meyer interviewed CEO Hanna Sjöström to discuss key takeaways, the company’s progress toward the clinical phase, and the upcoming first clinical study on preterm born...
Did you miss Neola Medical’s Q4 report presentation?
Catch up on key insights into Neola Medical’s latest developments as we prepare for clinical studies and continue strengthening our presence in the U.S. market. CEO Hanna Sjöström provides an update on key milestones and strategic progress in the U.S. and looks...
Highlights from Neola Medical’s Presentation at Redeye Technology & Life Science Day
Earlier this week, Neola Medical participated in the Redeye Technology and Life Science Day in Stockholm, showcasing the company’s significant progress and outlining its future plans during an engaging presentation and dynamic Q&A session. Discover deeper insights...
Neola Medical’s presentation at Stora Aktiedagarna in Stockholm
Yesterday CEO Hanna Sjöström showcased Neola Medical’s vision and strategic advancements during the presentation at Stora Aktiedagarna in Stockholm, highlighting the future of neonatal care. The presentation was met with great interest, filling the room with...
Neola Medical: Key Milestones & Future Plans at Redeye Medtech & Diagnostics Event 2024
Did you miss CEO Hanna Sjöström's investor presentation at the Redeye Theme: Medtech & Diagnostics Event 2024? Don’t worry—you can still catch up on all the exciting updates! In her presentation, CEO Hanna Sjöström highlighted Neola Medical’s significant...
The Q3 report presentation of 2024!
Watch when CEO Hanna Sjöström and CFO David Folkesson presented Neola Medical’s Q3-report of 2024. Learn more about the company’s financial position and the progress from this quarter, toward market approval in the U.S. After the presentation a brief Q&A...
CEO Hanna Sjöström visits Västra Hamnen Möter
The company's product for continuous lung monitoring of preterm born infants is attracting significant international interest. Watch CEO Hanna Sjöström and CEO Oscar Ahlgren at Västra Hamnen TV discuss Neola Medical’s promising study data, the substantial medical...
Q2 report commentary in the BioStock studio – The acquisition of the CB certification bolstered Neola Medical’s Q2
The second quarter of 2024 marked several milestones towards achieving market approval in the U.S. Notably, the company's medical device received CB certification, indicating that Neola®meets the required technical safety standards. Clinical trials are now on the...
The Q2 report presentation of 2024!
Did you miss all the exciting updates when CEO Hanna Sjöström and CFO Christian Gyllenberg presented Neola Medical’s Q2-report of 2024 at Finwire TV? Learn more about the company’s financial position and the important key achievements from this quarter, aimed at...
CEO and CFO presents the Q4 report of 2023
Apart from presenting the company’s financial position and the important highlights from this quarter, they also talk more about the significance of this year's achieved milestones, the commercialization plan for market launch, and the focus for 2024. After the...